Vanderbilt Researchers’ Potential Alzheimer’s Therapy Being Tested in Phase 1 Study

Vanderbilt Researchers’ Potential Alzheimer’s Therapy Being Tested in Phase 1 Study
Vanderbilt University researchers have developed a potential therapy for Alzheimer’s disease (AD) that has shown promising results in brain health. The investigative treatment, a molecule called VU319, is expected to fill a long-needed gap for Alzheimer’s patients by improving memory, attention, and brain functioning. The U.S. Food and Drug Administration (FDA) has cleared the drug to move

Knowledge is power when living with alzheimers.

Get access to the web’s leading Alzheimer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

One comment

  1. Linda Grishman says:

    How are these people getting into clinical trials? My doctor is useless so I have found my own sources. Albany Med Center has some promising results with a new drug. I will be going to Albany in the next few werks. I pray that it will clear the plaque and I will be back to my normal self. As you can see, I am still fully cognicent and that is a plus.

    Best,
    Linda Grishman.
    Burlington, VT

Leave a Comment

Your email address will not be published. Required fields are marked *